🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT05657366
Starting soon Not applicable

Peritoneal Lavage on the Incidence of Pancreatic Fistula and Related Complications After Pancreatoduodenectomy

NCT05657366 · tracked via the Priya Life Science China tracker
Sponsor
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase
Not applicable
Started
2023-05-01
Last updated
2023-04-21

Condition(s) studied

Pancreatic FistulaPancreaticoduodenal; Fistula

Investigational drug(s) / intervention(s)

Peritoneal lavage

Peritoneal lavage: Continuous abdominal flushing with normal saline

Study summary

As one of the possible strategies to prevent pancreatic fistula, peritoneal lavage is still widely used in clinical practice, but it lacks more evidence of evidence-based medicine and recommendations of guidelines. Some clinicians believe that routine flushing after pancreatoduodenectomy wastes medical resources and has a negative impact on patients' comfort.

In this study, the investigators designed a multicenter prospective controlled trial to compare the effects of peritoneal lavage and natural drainage on the incidence of pancreatic fistula and related complications after pancreatoduodenectomy. To study the indications of peritoneal lavage.

Eligibility

Sex
ALL
Min age
18 Years
Max age
80 Years
Healthy volunteers
No
Inclusion Criteria: 1. Preoperative diagnosis was pancreatic head, lower common bile duct, ampulla and duodenum tumors; 2. Patients with resectable tumors evaluated by imaging examination, and patients who plan to undergo pancreatoduodenectomy; 3. Subjects informed consent, understood and were willing to cooperate with the trial protocol, and signed relevant documents. Exclusion Criteria: 1. Complicated with severe liver, kidney, heart, brain, lung and other organ complications; 2. Intraoperative changes in surgical methods, such as patients with tumor dissemination and only abdominal opening and closing; Or it needs to be resected in combination with other organs; 3. Patients and their families do not understand the treatment implementation plan of this study; 4. Failure to complete follow-up;

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
The second affiliated hospital of Zhejiang University School of Medicine Hangzhou Zhejiang

More Second Affiliated Hospital, Zhejiang University, School of Medicine trials in China

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05657366 on ClinicalTrials.gov ↗ ← All trials in China